Figure 1: Diabetes treatment coverage in 55 low- and middle-income countries.

This figure displays coverage, or the proportion of eligible individuals receiving diabetes treatment, in 55 low-and middle-income countries. Each treatment is a core recommendation for people with type 2 diabetes in the 2020 World Health Organization Package of Essential Noncommunicable Disease Interventions. For the combined interventions, the denominator was all individuals who needed coverage for at least one treatment within the category; the numerator was the number of individuals self-reporting coverage for all treatments indicated for that individual within the category. For example, if an individual was defined to need glucose-lowering medication but not antihypertensive or cholesterol-lowering medication, the individual would be classified as having coverage for the pharmacological treatments if they self-reported use of the glucose-lowering medication (i.e., one out of only one indicated treatment). Conversely, if an individual was defined to need both glucose-lowering therapy and antihypertensive therapy, the individuals would not be classified as having coverage for the pharmacological treatments if the individual only self-reported use of the glucose-lowering medication (i.e., one out of two indicated interventions). Estimates account for clustering at the country level and equal weights by country. Error bars indicate 95% confidence intervals.